CureSight Mata Paie Togafitiga Masini e Kobi Kor

O le mamanu CureSight Mata Paie Togafitiga Masini e Kobi Kor o se manumalo maualuga tele o le fa'ailoga mamalu 2022 A' Design Award Uʻamea i le Vaega Tauva Oloa Fa'afoma'i.

UʻameaOloa Fa'afoma'i· 2022

CureSight Mata Paie Togafitiga Masini

na mamanuina e Kobi Kor

Tagata Fa'atau: Novasight

Manumalo o le A' Design Award Uʻamea i le Vaega Oloa Fa'afoma'i

22,237

Manumalo Fa'ailoga Fa'amaonia

Fa'amaonia le Tulaga o le Fa'ailoga mo #133911

Maua Nei Asiasi i le Saite Va'ai i le A' Design Award Fa'asalalauga Pailesi o le Fa'ailoga

Lanu

Le Mamanu

E Uiga ia CureSight Mata Paie Togafitiga Masini

O le faʻasologa o le mamanu a CureSight na taulaʻi i le fatuina o se oloa ma se fofo togafitiga o le a faia ai se aʻafiaga faʻaagafesootai lelei ma fesoasoani i tagata mamaʻi, o le toʻatele o tamaiti, e aloese ai mai le faʻalavelave ma le maasiasi o loʻo aʻafia i togafitiga masani ma le mata. O lo'o fa'amamafaina fo'i e le mamanu o foliga ma lagona ole oloa e taua ile fa'aosofia ma le fa'amalosia o tamaiti. O le musumusuga mo le faʻataʻitaʻiga mamanu na sau mai mea faʻatekonolosi e fiafia tamaiti e faʻaoga ma taʻalo ai. O le mamanu o foliga e maua ai se vaʻaiga faʻaonaponei ma faʻaonaponei mo se oloa masini faʻafomaʻi.

Le Fa'ailogaina

E Uiga i le A' Design Award Uʻamea

O le A' Design Award Uʻamea na manumalo ai CureSight Mata Paie Togafitiga Masini, o se faamaoniga mamalu e tuuina atu i mamanu lelei e faataunuu ai manaʻoga faapolofesa ma pisinisi e faamoemoeina mai galuega ua mamanuina lelei. O ē manumalo i le Uʻamea e faaalia ai le tomai tele, le faapitoa maualuga, le malamalama o tagata poto ma le mafai fatufatuaʻi o ē na faia. E faamoemoeina CureSight Mata Paie Togafitiga Masini e avea ma mea ua matuā vivii, mataʻina ma pelepelea e aogā ma fou. O lenei mamanu na manumalo i le A' Design Award Uʻamea e tuufaatasia ai faiga sili o le pisinisi ma e iai uiga faatekonolosi mafai ua fesoʻotaʻi ma le poto ma le taleni. Ona o lona faatuatuaina, e tatau ai CureSight Mata Paie Togafitiga Masini ona faaaloalogia ma ua mamanuina e tuuina mai ai faaleleiga o le olaga e fesoasoani e faia ai e le lalolagi se nofoaga e sili atu ona lelei.

I Tua o le Mamanu

Pepa Fa'asalalau

Fa'amaoniaga, sui o le 'au ma fa'amatalaga fa'atekinisi na saunia e le tagata mamanu.

Uiga Fa'apitoa: The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Fua & Fa'apipi'i: product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Fa'ailoga: amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Tekonolosi Gaosiga: The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Lu'itau o le Mamanu: The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Su'esu'ega: Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Fa'aosofia: The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Umi o le Poloketi: The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Fa'agasologa o Galuega: The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Sui o le 'Au: Kobi Kor
Tal Samet
Fa'aaloaloga o Ata: All images
Photograph and Illustrations: Novasight and Kobi Kor